Molecular genetics of chromosome translocations involving EWS and related family members

Physiological Genomics

Volumn 1999, Issue 1, 1999, Pages 127-138

  Kim, Jungho ^a   Pelletier, Jerry ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer genetics; EWS; Oncogene; Transformation

Indexed keywords

DNA BINDING PROTEIN; EWS FLI FUSION PROTEIN; EWS-FLI FUSION PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; ONCOPROTEIN; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR; WT1 PROTEIN;

EWING SARCOMA; GENE TRANSLOCATION; GENETICS; HUMAN; NEPHROBLASTOMA; REVIEW;

DNA-BINDING PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; ONCOGENE PROTEINS, FUSION; RIBONUCLEOPROTEINS; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; WILMS TUMOR; WT1 PROTEINS;

EID: 0033547265     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.1999.1.3.127     Document Type: Review

References (114)

1. Amson, R. B., M. Nemani, J. P. Roperch, D. Israeli, L. Bougueleret, I. Le Gall, M. Medhioub, G. Linares-Cruz, F. Lethrosne, P. Pasturaud, L. Piouffre, S. Prieur, L. Susini, V. Alvaro, P. Millasseau, C. Guidicelli, H. Bui, C. Massart, L. Cazes, F. Dufour, H. Bruzzoni-Giovanelli, H. Owadi, C. Hennion, G. Charpak, J. Dausset, F. Calvo, M. Oren, D. Cohen, and A. Telerman. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the Drosophila seven in absentia gene. Proc. Natl. Acad. Sci. USA 93: 3953-3957, 1996.
2. Bailly, R. A., R. Bosselut, J. Zucman, F. Cormier, O. Delattre, M. Roussel, G. Thomas, and J. Ghysdael. DNA-binding and transcriptional activation properties of the fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14: 3230-3241, 1994.
3. Barone, M. V., A. Crozat, A. Tabaee, L. Philipson, and D. Ron. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have oppositing effects on the induction of G1/S arrest. Genes Dev. 8: 453-464, 1994.
4. Ben-David, Y., E. B. Giddens, K. Letwin, and A. Bernstein. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5: 908-918, 1991.
5. II68, a novel RNA/ssDNA-binding protein with homology to the prooncoproteins TLS/FUS and EWS, is associated with both TFIID and RNA polymerase II. EMBO J. 15: 5022-5031, 1996.
6. II68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell. Biol. 18: 1489-1497, 1998.
7. Bickmore, W. A., K. Oghene, M. H. Little, A. Seawright, V. van Heyningen, and N. D. Hastie. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor wtl gene transcript. Science 257: 235-237, 1992.
8. Biegel, J. A., K. Conard, J. J. Brooks. Translocation (11; 22)(p13;q12): primary change in intraabdominal desmoplastic small round cell tumor. Genes Chromosome Cancer 7: 119-121, 1993.
9. Bird, A. CpG-rich island and the function of DNA methylation. Nature 321: 209-213, 1986.
10. Bonin, G., C. Scamps, C. Turc-Carel, and M. Lipinski. Chimeric EWS-Fli1 transcript in a Ewing cell line with a complex t(11;22;14) translocation. Cancer Res. 53: 3655-3657, 1993.
11. Braun, B. S., R. Frieden, S. L. Lessnick, W. A. May, and C. T. Denny. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol. Cell. Biol. 15: 4623-4630, 1995.
12. Brou, C., S. Chaudhary, I. Davison, Y. Lutz, J. Wu, J. M. Egly, L. Tora, and P. Chambon. Distinct TFIID complexes mediate the effect of different transcription activators. EMBO J. 12: 489-499, 1993.
13. Brown, A. D., D. Lopez-Terrada, C. T. Denny, and K. A. W. Lee. Promoters containing ATF-binding sites are deregulated in cells that express the EWS/ATF1 oncogene. Oncogene 10: 1749-1756, 1995.
14. Brown, T. A., and S. L. McKnight. Specificities of protein-protein and protein-DNA interaction of GABP-α and two newly defined ets-related proteins. Genes Dev. 6: 2502-2512, 1992.
15. Butterwith, S. C. Molecular events in adipocyte development. Pharmacol. Ther. 61: 399-411, 1994.
16. Call, K. M., T. Glaser, C. Y. Ito, A. J. Buckler, J. Pelletier, D. A. Haber, E. A. Rose, A. Kral, H. Yeger, W. H. Lewis, C. Jones, and D. E. Housman. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumor locus. Cell 60: 509-520, 1990.
17. Chung, E. B., and F. M. Enzinger. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am. J. Surg. Pathol. 7: 405-413, 1983.
18. Clark J., H. Benjamin, S. Gill, S. Sidhar, G. Goodwin, J. Crew, B. A. Gusterson, J. Shipley, and C. S. Cooper. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chodrosarcoma. Oncogene 12: 229-235, 1996.
19. Corden, J. L. Tails of RNA polymerase II. Trends Biochem. Sci. 15: 383-387, 1990.
20. Crepieux, P., J. Cell, and D. Stehelin. The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncogene 5: 615-638, 1994.
21. Crozat, A., P. Aman, N. Mandahl, and D. Ron. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640-644, 1993.
22. Davies, R. C., C. Calvio, E. Bratt, S. H. Larsson, A. I. Lamond, and N. D. Hastie. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incoporated into spliceosomes. Genes Dev. 12: 3217-3225, 1998.
23. Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, and G. Thomas. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165, 1992.
24. Deloulme, J. C., L. Prichard, O. Delattre, and D. R. Storm. The protooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through IQ domain. J. Biol. Chem. 272: 27369-27377, 1997.
25. Drummond, I. A., H. D. Rupprecht, P. Rohwer-Nutter, J. M. Lopez-Guisa, S. L. Madden, F. J. Rauscher III, and V. P. Sukhatme. DNA recognition by variants of the Wilms' tumor suppressor, WT1. Mol. Cell. Biol. 14: 3800-3809, 1994.
26. Fujimura, Y., T. Ohno, H. Siddique, L. Lee, V. N. Rao, and E. S. P. Reddy. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 12: 159-167, 1996.
27. Gerald, W. L., M. Ladanyi, E. de Alava, M. Cuatrecasas, B. H. Kushner, M. P. LaQuaglia, and J. Rosai. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J. Clin. Oncol. 16: 3028-3036, 1998.
28. Gerald, W. L., J. Rosai, and M. Ladanyi. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc. Natl. Acad. Sci. USA 92: 1028-1032, 1995.
29. Gerendasy, D. D., S. R. Herron, J. B. Watson, and J. G. Sutcliffe. Mutational and biophysical studies suggest RC3/ neurogranin regulates calmodulin availability. J. Biol. Chem. 269: 22420-22426, 1994.
30. Gessler, M., A. Poustka, W. Cavenee, R. L. Neve, S. H. Orkin, and G. A. Bruns. Homozygous deletions in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990.
31. Haber, D. A., R. L. Sohn, A. J. Buckler, J. Pelletier, K. M. Call, and D. E. Housman. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA 88: 9618-9622, 1991.
32. Hallier, M., A. Lerga, S. Barnache, A. Tavitian, and F. Moreau-Gachelin. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273: 4838-4842, 1998.
33. Haynes, S. R. The RNP motif protein family. New Biologist 4: 421-429, 1992.
34. Hibshoosh, H., and R. Lattes. Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer. Semin. Oncol. 24: 515-525, 1997.
35. Higashino, F., K. Yoshida, Y. Fujinaga, K. Kamio, and K. Fujinaga. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: a new human member of the ets oncogene family. Nucleic Acids Res. 21: 547-553, 1993.
36. Higashino, F., K. Yoshida, T. Noumi, M. Seiki, and K. Fujinaga. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10: 1461-1463, 1995.
37. Ichikawa, H., K. Shimizu, Y. Hayashi, and M. Ohki. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res. 54: 2865-2868, 1994.
38. Immanuel, D., H. Zinszner, and D. Ron. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell Biol. 15: 4562-4571, 1995.
39. Jacq, X., C. Brou, Y. Lutz, I. Davison, P. Chambon, and L. Tora. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79: 107-117, 1994.
40. Jeon, I.-S., J. N. Davis, B. S. Braun, J. E. Sublett, M. F. Roussel, C. T. Denny, and D. N. Shapiro. A variant Ewings sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10: 1229-1234, 1995.
41. Johnstone, R. W., R. H. See, S. F. Sells, J. Wang, S. Muthukkumar, C. Englert, D. A. Haber, J. D. Licht, S. P. Sugrue, T. Roberts, V. M. Rangnekar, and Y. Shi. A novel repressor, par-4, modulates transcription and growth suppression function of the Wilms' tumor suppressor WT1. Mol. Cell. Biol. 16: 6945-6956, 1996.
42. Kaneko, Y., K. Yoshida, M. Handa, Y. Toyoda, H. Nishikira, Y. Tanaka, Y. Sasaki, S. Ishida, F. Higasgino, and K. Fujinaga. Fusion of an ETS-family gene, E1AF, to EWS by the t(17;22)(q12;q12) chromosome translocation in an undifierentiated sarcoma of infancy. Genes Chrom. Cancer 15: 115-121, 1996.
43. Kenan, D. J., C. C. Query, and J. D. Keene. RNArecognition: towards identifying determinants of specificity. Trends Bioehem. Sci. 16: 214-220, 1991.
44. Kiledjian, M., and G. Drefuss. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 11: 2655-2664, 1992.
45. Kim, J., K. Lee, and J. Pelletier. The DNAbinding domains of the WT1 tumor suppressor gene product and chimeric EWS/ WT1 oncoprotein are functionally distinct. Oncogene 16: 1021-1030, 1998.
46. Kim, J., K. Lee, and J. Pelletier. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Oncogene 16: 1973-1979, 1998.
47. Kim, J., J. M. Lee, P. E. Branton, and J. Pelletier. Modification of EWS/VT1 functional properties by phosphorylation. Proc. Nat. Acad. Sci. USA In press.
48. Kumar, A., J. R. Cassas-Finet, C. J. Luneau, R. L. Karpel, B. M. Merrill, K. R. Williams, and S. H. Wilson. Mammalian heterogeneous nuclear ribonucleoprotein A1. J. Biol. Chem. 265: 17094-17100, 1990.
49. Kumar, A., and S. H. Wilson. Studies of the strand-annealing activity of mammalian hnRNP complexes Protein A1. Biochemistry 29: 10717-10722, 1990.
50. Kuroda, M., T. Ishida, M. Takanashi, M. Satoh, R. Machinami, and T. Watanabe. Oncogenic transformation and inhibition of adipocytic conversion of preadipocysts by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 151: 735-744, 1997.
51. Labelle, Y., J. Bussières, F. Courjal, and M. B. Goldring. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene 18: 3303-3308, 1999.
52. Labelle, Y., J. Zucman, G. Stenman, L. G. Kindblom, J. Knight, C. Turc-Carel, B. Dockhorn-Dworniczak, N. Mandahl, C. Desmaze, M. Peter, A. Aurias, O. Delattre, and G. Thomas. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum. Mol. Genet. 4: 2219-2226, 1995.
53. Ladanyi, M., and W. Gerald. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54: 2837-2840, 1994.
54. Lee, S. B., K. A. Kolquist, K. Nichols, C. Englert, S. Maheswaran, M. Ladanyi, W. L. Gerald, and D. A. Haber. The EWS/WT1 translocation product induces PDGFA in desmo-plastic small round cell tumour. Nat. Genet. 17: 309-313, 1997.
55. Lee, K. A. W., and N. Masson. Transcriptional regulation by CREB and its relatives. Biochim. Biophys. Acta 1174: 221-233, 1993.
56. Lessnick, S. L., B. S. Braun, C. T. Denny, and W. A. May. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FL1-1 fusion gene. Oncogene 10: 423-431, 1995.
57. Lipinski, M., K. Braham, I. Philip, J. Wiels, T. Philip, C. Goridis, G. M. Lenoir, and T. Tursz. Neuroectoderm-associated antigenes on Ewing's sarcoma cell lines. Cancer Res. 47: 183-187, 1987.
58. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukhatme, and F. J. Rauscher III. Transcriptional repression mediated by the WT1 Wilms' tumor suppressor product. Science 253: 1550-1553, 1991.
59. Maheswaran, S., C. Englert, G. Zheng, S. B. Lee, J. Wong, D. P. Harkin, J. Bean, R. Ezzell, A. J. Garvin, R. T. McCluskey, J. A. DeCaprio, and D. A. Haber. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 requires association with the inducible chaperon Hsp70. Genes Dev. 12: 1108-1120, 1998.
60. Maheswaran, S., S. Park, A. Bernard, J. F. Morris, F. J. Rauscher, D. E. Hill, and D. A. Haber. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA 90: 5100-5104, 1993.
61. Mao, X., S. Miesfeldt, H. Yang, J. M. Leiden, and C. B. Thomson. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar specificities. J. Biol. Chem. 269: 18216-18222, 1994.
62. May, W. A., A. Arvand, A. D. Thomson, B. S. Braun, M. Wright, and C. T. Denny. EWS/FLI1-induced manic fringe renders NIH/3T3 cells tumorigenic. Nat. Genet. 17: 495-497, 1997.
63. May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Lunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. Ewing sarcoma 11;22 translocation produces a chimeric factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90: 5752-5756, 1993.
64. May, W. A., S. L. Lessnick, B. S. Braun, M. Klemsz, B. C. Lewis, L. B. Lunsford, R. Hromas, and C. T. Denny. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more transcriptional activator and is a more powerful transforming FLI-1. Mol. Cell. Biol. 13: 7393-7398, 1993.
65. Moffett, P., W. Bruening, H. Nakagama, N. Bardeesy, D. Housman, D. E. Housman, and J. Pelletier. Antagonism of WT1 activity by protein self-association. Proc. Natl. Acad. Sci. USA 92: 11105-11109, 1995.
66. Nakagama, H., G. Heinrich, J. Pelletier, and D. E. Housman. Sequence and structural requirements for high-affinity DNA-binding by the WT1 gene product. Mol. Cell. Biol. 15: 1489-1498, 1995.
67. Ohno, T., M. Ouchida, L. Lee, Z. Gatalica, V. N. Rao, and E. S. P. Reddy. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9: 3087-3097, 1994.
68. Ohno, T., V. N. Rao, and E. S. Reddy. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53: 5859-5863, 1993.
69. Ouchida, M., T. Ohno, Y. Fujimura, V. N. Rao, and E. S. P. Reddy. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 11: 1049-1054, 1995.
70. Panagopoulos, I., P. Åman, T. Fioretos, M. Höglund, B. Johansson, N. Mandahl, S. Heim, M. Behrendtz, and F. Mitelman. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chrom. Cancer 11: 256-262, 1994.
71. Panagopoulos, I., M. Höglund, F. Mertens, F. Mandahl, Mitelman, and P. Åman. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 12: 489-494, 1996.
72. Park, J. S., J. D. Luethy, M. G. Wang, J. Fargnoli, A. J. Fornace, Jr., O. W. McBride, and N. J. Holbrook. Isolation, characterization and chromosomal localization of the human GADD153 gene. Gene 116: 259-267, 1992.
73. Pelletier, J., W. Bruening, C. E. Kashtan, S. M. Mauer, J. C. Manivel, J. E. Striegel, D. C. Houghton, C. Junien, R. Habib, L. Fouser, R. L. Fine, B. L. Silverman, D. A. Haber, and D. Housman. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437-447, 1991.
74. Peter, M., J. Couturier, H. Pacquement, J. Michon, G. Thomas, H. Magdelenat, and O. Delattre. Anew member of the ETS family fused to EWS in Ewing tumors. Oncogene 14: 1159-1164, 1997.
75. Pio, F., R. Kodandapani, C. Z. Ni, W. Shepard, M. Klemsz, S. R. McKercher, R. A. Maki and K. R. Ely. New insights on DNA recognition by ets proteins from the crystal structure of the PU.1 ETS domain-DNA complex. J. Biol. Chem. 271: 23329-23337, 1996.
76. Plougastel, B., I. Zucman, M. Peter, G. Thomas, and O. Delattre. Genomic structure of the EWS gene and its relationship to EWSRl: a site of tumor-associated chromosome translocation. Genomics 18: 600-615, 1993.
77. Prasad, D. D., M. Ouchida, L. Lee, V. N. Rao, and E. S. Reddy. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9: 3717-3729, 1994.
78. Prasad, D. D., V. N. Rao, and E. S. Reddy. Structure and expression of human Fli-1 gene. Cancer Res. 52: 5833-5837, 1992.
79. Rabbits, T. H. Chromosomal translocations in human cancer. Nature 372: 143-149, 1994.
80. Rabbits, T. H., A. Forster, R. Larson, and P. Nathan. Fusion of the dominant negative tran-scription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4: 175-180, 1993.
81. Rauscher, F. J. III, L. E. Benjamin, W. J. Fredericks, and J. F. Morris. Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewing's sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor. Proc. LIX Cold Spring Harbor Symposia Quant. Biol. 1994, p. 137-146.
82. Rauscher F. J. III, J. F. Morris, O. E. Tournay, D. M. Cook, and T. Curran Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250: 1259-1262, 1990.
83. Reddy, J. C., and J. D. Licht. The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim. Biophys. Acta 1287: 1-28, 1996.
84. Reddy, J. C., J. C. Morris, J. Wang, M. A. English, D. A. Haber, Y. Shi, and J. D. Licht. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270: 10878-10884, 1995.
85. Reddy, E. S., V. N. Rao, and T. S. Papas. The erg gene: a human gene related to ets oncogene. Proc. Natl. Acad. Sci. USA 84: 6131-6135, 1987.
86. Ribeiro, A., A. D. Brown, and K. A. W. Lee. An in vivo assay for members of the cAMP responsive element-binding protein family of transcription factors. J. Biol. Chem. 269: 31124-31128, 1994.
87. Rodriguez, E., C. Sreekantaiah, W. Gerald, V. E. Reuter, R. J. Motzer, and R. S. Chaganti. A recurring translocation, t(11;22)(p13;q11.2), characterizes intraabdominal desmoplastic small round cell tumors. Cancer Genet. Cytogenet. 69: 17-21, 1993.
88. Ron, D., A. R. Braisier, R. E. McGehee, Jr., and J. F. Habener. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C-EBP). J. Clin. Invest. 89: 223-233, 1992.
89. Ron, D. and J. F. Habener. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6: 439-453, 1992.
90. Sakamoto, Y., M. Yoshida, K. Semba, and T. Hunter. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Oncogene 15: 2001-2012, 1997.
91. Sawyer, J. R., A. F. Tryka, and J. M. Lewis. A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am. J. Surg. Pathol. 16: 411-416, 1992.
92. Shen, W. P., B. Towne, and T. M. Zadeh. Cytogenetic abnormalities in an intra-abdominal desmoplastic small cell tumor. Cancer Genet. Cytogenet. 64: 189-191, 1992.
93. Shimizu, K., H. Ichikawa, H. Tojo, Y. Kaneko, N. Maseki, Y. Hayashi, M. Ohira, S. Asano, and M. Ohki. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(11;21) chromosomal translocation. Proc. Natl. Acad. Sci. USA 90: 10280-10284, 1993.
94. Sorensen, P. H., S. L. Lessnick, D. Lopez-Terrada, X. F. Liu, T. J. Triche, and C. T. Denny. A second Ewings sarcoma translocation t(21;22) fuses the EWS gene to another ETS-family transcription factor ERG. Nat. Genet. 6: 146-151, 1994.
95. Squire, J., M. Zielenska, P. Thorner, S. Tennyson, S. Weitzman, K. M. Pai, H. Yeger, Y. K. Ng, and R. Weksberg. Varient translocations of chromosome 22 in Ewing's sarcoma. Genes Chromosome Cancer 8: 190-194, 1993.
96. Sreekantiaiah, S., C. P. Karakousis, S. P. L. Leong, and A. A. Sandberg. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 69: 2484-2495, 1992.
97. Stolow, D. T., and S. R. Haynes. Cabeza, a Drosophila gene encoding a novel RNA-binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 23: 835-843, 1995.
98. Thompson, A. D., B. S. Braun, A. Arvand, S. D. Stewart, W. A. May, E. Chen, J. Korenberg, and C. Denny. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13: 2649-2658, 1996.
99. Triche, T. J. Ewing's sarcoma (peripheral PNET). Encyclopedia of Cancer. Boston, MA: Academic, 1997, vol. 1, p. 652-659.
100. Trimble, M. S., J. H. Xin, C. T. Guy, W. J. Muller, and J. A. Hasseil. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas Oncogene 8: 3037-3042, 1993.
101. Turc-Carel, C., J. Limon, P. Dal Cin, U. Rao, C. Karakousis, and A. A. Samdberg. Cytogenetic studies of adipose tissue tumors. II. Recurrent receiprocal translocation t(12;16)(q13; p11) in myxoid liposarcomas. Cancer Genet. Cytogenet. 23: 291-299, 1986.
102. Urano, F., A. Umezawa, H. Yabe, W. Hong, K. Yoshida, K. Fujinaga, and J.-I. Hata. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis. Jpn. J. Cancer Res. 89: 703-711, 1998.
103. Wang, Z.-Y., Q.-Q. Qui, and T. F. Deuel. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem. 268: 9172-9175, 1993.
104. Wang, Z.-Y., Q.-Q. Qui, K. T. Enger, and T. F. Deuel. A second transcriptionally active DNA-binding site for Wilms' tumor gene product, WT1. Proc. Natl. Acad. Sci. USA 90: 8896-8900, 1993.
105. Wang, Z.-Y., Q.-Q. Qui, J. Huang, M. Gurrieri, and T. F. Deuel. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10: 415-422, 1995.
106. Werner, M. H., M. Clore, C. L. Fisher, R. J. Fisher, L. Trinh, J. Shiloach, and A. M. Gronenborn. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell 83: 761-771, 1995.
107. Yang, L., L. J. Embree, S. Tsai, and D. D. Hickstein. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273: 27761-27764, 1998.
108. Ye, Y., B. Raychaudhuri, A. Gurney, C. E. Campbell, and B. R. G. Williams. Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J. 15: 5606-5615, 1996.
109. Yi, H.-K., Y. Fujimura, M. Ouchida, D. D. K. Prasad, V. N. Rao, and E. S. P. Reddy. Inhibition of apoptosis by normal and aberrant FIi-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14: 1259-1268, 1997.
110. Zhang, D., A. J. Paley, and G. Childs. The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J. Biol. Chem. 273: 18086-18091, 1998.
111. Zinszner, H., R. Albalat, and D. Ron. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8: 2513-2526, 1994.
112. Zinszner, H., J. Sok, D. Immanuel, Y. Yin, and D. Ron. TLS(FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110: 1741-1750, 1997.
113. Zucman, J., O. Delattre, C. Desmaze, A. L. Epstein, G. Stenman, F. Speleman, C. D. Fietcher, A. Aurias, and G. Thomas. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat. Genet. 4: 341-345, 1993.
114. Zucman, J., T. Melot, C. Desmaze, I. Ghysdael, B. Plougastel, M. Peter, J. M. Zucker, T. J. Triche, D. Sheer, C. Turc-Carel, P. Ambros, V. Combaret, G. Lenoir, A. Aurias, G. Thomas, and O. Delattre. Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J. 12: 4481-4487, 1993.